HomeAI · summaries
Storia in 2 fonti
Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M
Alkeus brought to late-stage testing a Stargardt disease therapy that former executive chairman and Vertex founder Josh Boger once called, “if it works, the most perfect drug I’ve ever seen.”
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M
Alkeus brought to late-stage testing a Stargardt disease therapy that former executive chairman and Vertex founder Josh Boger once called, “if it works, the most perfect drug I’ve…
- ·
endpoints.news
Tarsus bets $450M on Alkeus’ Stargardt drug
Tarsus Pharmaceuticals is broadening its ophthalmology portfolio by purchasing Alkeus Pharmaceuticals, its second acquisition in as many months.